about
Pharmacological Alternatives for the Treatment of Neurodegenerative Disorders: Wasp and Bee Venoms and Their Components as New Neuroactive ToolsSystems biology of neurodegenerative diseasesPatients experiences of maintaining mental well-being and hope within motor neuron disease: a thematic synthesis.The ALS/FTLD associated protein C9orf72 associates with SMCR8 and WDR41 to regulate the autophagy-lysosome pathway.Cognitive-behavioral screening reveals prevalent impairment in a large multicenter ALS cohort.ALS-FTD complex disorder due to C9ORF72 gene mutation: description of first Polish family.The neurogenetics of atypical parkinsonian disordersPersonality disturbances in amyotrophic lateral sclerosis: a case study demonstrating changes in personality without cognitive deficits.TDP-43 protein variants as biomarkers in amyotrophic lateral sclerosis.The wobbler mouse, an ALS animal model.The phenotypic variability of amyotrophic lateral sclerosis.Traumatic brain injury: a risk factor for neurodegenerative diseases.Overstimulation of the inhibitory nervous system plays a role in the pathogenesis of neuromuscular and neurological diseases: a novel hypothesis.Extra-motor abnormalities in amyotrophic lateral sclerosis: another layer of heterogeneity.New routes in frontotemporal dementia drug discovery.Accrued somatic mutations (nucleic acid changes) trigger ALS: 2005-2015 update.Neuroprotective Potential of Cell-Based Therapies in ALS: From Bench to Bedside.A proteomic network approach across the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain.Executive dysfunction and survival in patients with amyotrophic lateral sclerosis: Preliminary report from a Serbian centre for motor neuron disease.Cognitive impairment in ALS patients and validation of the Spanish version of the ALS-CBS test.
P2860
Q26795786-37801517-DD2D-447C-B700-5DB602C66732Q28080741-1D2865D2-931E-45CA-A61B-C1A6BDA6327FQ28082466-44A90D89-BC32-4481-B6A1-D62D437D16E9Q29465536-A973160E-1F0B-47C5-BF4E-8DD0FE9FD52AQ30728028-A183E5C3-59EC-40DD-B2A9-12AAB3664E33Q30826743-E116F173-4579-40E4-81A3-6D870CE276BAQ35008908-F2CA0352-4503-459D-9669-EA9C63F5976CQ35601033-FAE5D932-C20E-4DA3-81C8-7735C70A5EADQ36260146-298E622F-0C22-4F83-99B2-CF752189F029Q36878198-E600E791-3F92-4E58-B42E-5731DCBEE5F8Q38259758-6B0CCBD6-E63D-4788-A94A-7FEE6B5649E7Q38583420-2DCA90F8-5883-4927-97D8-959C9F864201Q38933657-A77AF9CB-D922-42AB-9868-7A10DDC063E2Q39041271-83BE7EEA-14BF-4618-9E3A-9FA7D78AAB54Q39344391-9728DB91-948B-4A6D-AEF1-EAE694805ACEQ40957607-34E0C551-3D56-4FBB-9499-9DEC60084455Q45874124-7E6D324E-9214-4099-8C22-B2199D95DBCDQ47344945-9131B1D3-75C1-4445-B72F-F1A306B48ED7Q47966341-2B4B9C0D-2CF7-425F-9576-F157F79C4DD3Q50547770-D023611D-A0FA-4B3D-8DFA-DE8B7BCE4C5A
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
ALS and Frontotemporal Dysfunction: A Review.
@ast
ALS and Frontotemporal Dysfunction: A Review.
@en
type
label
ALS and Frontotemporal Dysfunction: A Review.
@ast
ALS and Frontotemporal Dysfunction: A Review.
@en
prefLabel
ALS and Frontotemporal Dysfunction: A Review.
@ast
ALS and Frontotemporal Dysfunction: A Review.
@en
P2860
P356
P1476
ALS and Frontotemporal Dysfunction: A Review.
@en
P2093
Eugene Y Achi
Stacy A Rudnicki
P2860
P304
P356
10.1155/2012/806306
P577
2012-08-07T00:00:00Z